Cite
HARVARD Citation
Assi, R. et al. (n.d.). A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms. American journal of hematology. 93 (2), pp. 277-285. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Assi, R. et al. (n.d.). A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms. American journal of hematology. 93 (2), pp. 277-285. [Online].